市場調査レポート

商品コード

人工呼吸器の世界市場：可動性別、タイプ別、インターフェース別、方式別、ケア環境別 - 予測（～2029年）

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029

出版日: 2025年02月26日
発行: MarketsandMarkets
ページ情報: 英文 292 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 4,950 727,600円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (5-user License)

USD 6,650 977,483円

レポートPDFを同じ国内の同じ事業所内の5名迄にて共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 8,150 1,197,968円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありませんが、同一国内にある事業所のみとなり、海外支店などは含まれません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Global License)

USD 10,000 1,469,900円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。100％子会社は同一企業とみなされます。PDF内のテキスト等のコピー＆ペースト可能です。PDの印刷は何回でも可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の人工呼吸器の市場規模は、2024年の37億1,000万米ドルから2029年までに46億6,000万米ドルに達すると予測され、予測期間にCAGRで4.7%の成長が見込まれます。

調査範囲
調査対象年	2021年～2029年
基準年	2023年
予測期間	2024年～2029年
単位	米ドル
セグメント	タイプ、年齢層、インターフェース、方式、ケア環境、地域
対象地域	北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ、GCC諸国

COPDや喘息などの呼吸器疾患の増加は、人工呼吸器市場の主な促進要因です。大気汚染レベルの上昇、ライフスタイルの変化、高齢化により、これらの慢性疾患が増加し、呼吸器発作の頻度や重症度が高まっています。COPDや重度の喘息の患者は、急性増悪時に呼吸器の支援を頻繁に必要とするため、病院や在宅ケアの侵襲的・非侵襲的人工呼吸器に対する需要が増加しています。さらに、安全性、精度、患者の転帰といった人工呼吸器技術の進歩が続いているため、医療従事者は新しい呼吸補助装置への投資を促されています。まとめると、呼吸器疾患の負担の増加が市場成長の促進要因となっています。

「ハイエンドICU人工呼吸器セグメントが世界の人工呼吸器市場で最大のシェアを占めます。」

プレミアムICU人工呼吸器は、集中治療室での生命を脅かす状況の治療に不可欠であることから、世界の人工呼吸器市場で最大のシェアを占めています。このようなハイエンド機器は、包括的で多様な換気方式、先進のモニタリングシステム、改良された安全機能を備えており、重症患者に必要です。世界の高齢化と先進の呼吸器疾患の流行により、医療施設は次世代ICUソリューションへの投資を積極的に行っています。さらに、進行中の開発と規制機関による厳格な基準が、これらの先進の機器の使用を後押ししており、患者の最大の転帰を達成しなければならない生命にかかわる用途では、これらが最適な選択肢となっています。

「複合方式人工呼吸器が人工呼吸器市場で最大の市場シェアを占めています。」

従量式換気と従圧式換気のもっとも有利な面を提供し、臨床医が呼吸支援を患者の個々のニーズに合わせてカスタマイズできるようにすることから、複合方式人工呼吸器が人工呼吸器セグメントでもっとも高い市場シェアを占めています。この製品は、臨床医が肺を傷つけないように圧力を制限しながら、換気量を正確にコントロールすることを可能にし、それによって、さまざまな臨床状況に対応できる多用途のソリューションを提供します。対になったハイテクモニタリングシステムと自動調整機能は、利便性を高めるだけでなく、患者の転機も向上させます。したがって、複合方式人工呼吸器は、ダイナミックで柔軟な換気方式を必要とする重症患者を抱える集中治療室で大きな需要があります。さらに、絶え間ない技術革新、医療施設に対する支出の増加、呼吸器疾患の増加などが、複合方式人工呼吸器を市場のトップに押し上げる役割を果たしています。

「欧州は人工呼吸器市場で第2位のシェアを占めています。」

欧州は世界第2位の人工呼吸器市場であり、確立された医療インフラ、多額の政府支出、最高品質な製品を保証する厳しい規制を有しています。欧州では集中治療室や病院が広くカバーされており、呼吸器疾患の罹患率が高く、高齢化も進んでいるため、侵襲的人工呼吸器だけでなく非侵襲的人工呼吸器の需要も増加しています。

さらに、欧州には一流のメーカーが集う活気あるコミュニティがあり、絶え間ない技術革新により、患者の治療成績を向上させる超現代的技術の開発が進んでいます。将来を見据えた医療対策と包括的な保険制度により、欧州は世界の人工呼吸器市場において強力な市場であり、第2位の市場シェア保持者としての地位を保証しています。

当レポートでは、世界の人工呼吸器市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

イントロダクション
市場力学
- 促進要因
- 抑制要因
- 機会
- 課題
産業動向
- 高性能ポータブル人工呼吸器の需要の増加
- 市場の統合
- マルチモーダル人工呼吸器の需要の増加
- 非侵襲的人工呼吸器の採用の増加
技術分析
- 主要技術
- 補完技術
- 隣接技術
価格分析
- 人工呼吸器の参考価格：主要企業別
- 平均販売価格の動向：地域別
バリューチェーン分析
エコシステム分析
サプライチェーン分析
ポーターのファイブフォース分析
主なステークホルダーと購入基準
規制分析
- 規制機関、政府機関、その他の組織
- 規制枠組み
特許分析
貿易分析
- 人工呼吸器の輸出データ（HSコード9018）
- 人工呼吸器の輸入データ（HSコード9018）
主な会議とイベント（2023年～2024年）
償還シナリオ
アンメットニーズとエンドユーザーの期待
顧客のビジネスに影響を与える動向/混乱
投資と資金調達のシナリオ
隣接市場の分析
- 呼吸器診断市場
- 睡眠時無呼吸症候群機器市場
人工呼吸器市場に対するAI/生成AIの影響
- イントロダクション
- 医療の未来 - ビッグデータとAI
- 換気管理向けナレッジベースシステム

第6章人工呼吸器市場：タイプ別

イントロダクション
集中治療用人工呼吸器
ポータブル/可搬型人工呼吸器

第7章人工呼吸器市場：年齢層別

イントロダクション
成人/小児用人工呼吸器
新生児/乳児用人工呼吸器

第8章換気市場：インターフェース別

イントロダクション
ハイブリッド換気
非侵襲的換気
侵襲的換気

第9章人工呼吸器市場：方式別

イントロダクション
複合方式人工呼吸器
従量式人工呼吸器
従圧式人工呼吸器
その他の人工呼吸器

第10章人工呼吸器市場：ケア環境別

イントロダクション
病院・診療所
外来ケアセンター
緊急医療サービス
在宅ケア環境

第11章人工呼吸器市場：地域別

イントロダクション
北米
- 北米のマクロ経済の見通し
- 米国
- カナダ
欧州
- 欧州のマクロ経済の見通し
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- オランダ
- その他の欧州
アジア太平洋
- アジア太平洋のマクロ経済の見通し
- 日本
- 中国
- インド
- オーストラリア
- その他のアジア太平洋
ラテンアメリカ
- ラテンアメリカのマクロ経済の見通し
- ブラジル
- メキシコ
- アルゼンチン
- その他のラテンアメリカ
中東・アフリカ
GCC諸国

第12章競合情勢

概要
主要参入企業の戦略/強み
収益分析（2019年～2023年）
市場シェア分析（2023年）
企業の評価マトリクス：主要企業（2023年）
企業の評価マトリクス：スタートアップ/中小企業（2023年）
人工呼吸器市場：研究開発費
企業の評価と財務指標
ブランド/製品の比較
競合シナリオ

第13章企業プロファイル

主要企業
- RESMED
- GETINGE AB
- KONINKLIJKE PHILIPS N.V.
- DRAGERWERK AG & CO. KGAA
- ICU MEDICAL INC.
- ASAHI KASEI CORPORATION
- AIR LIQUIDE
- FLEXICARE (GROUP) LIMITED
- NIHON KOHDEN CORPORATION
- SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
- GE HEALTHCARE
- BAXTER
- VYAIRE MEDICAL, INC.
- HAMILTON MEDICAL
その他の企業
- SKANRAY TECHNOLOGIES, LTD.
- AXCENT MEDICAL GMBH
- METRAN CO., LTD.
- MAGNAMED
- LEISTUNG INGENIERIA SRL
- AVASARALA TECHNOLOGIES LIMITED
- AIRON CORPORATION
- TRITON ELECTRONIC SYSTEMS LTD.
- BIO-MED DEVICES, INC.
- HEYER MEDICAL AG
- AGVA HEALTHCARE
- BIODESIGN INNOVATION LABS
- NOCCARC ROBOTICS PVT LTD
- UMBULIZER
- SCHILLER HEALTHCARE INDIA PVT. LTD
- AVI HEALTHCARE

第14章付録

図表

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 RISK ASSESSMENT
TABLE 3 DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2024
TABLE 4 INDUSTRY TRENDS IN VENTILATORS MARKET
TABLE 5 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2024 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION, 2022-2024 (USD)
TABLE 7 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
TABLE 8 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 9 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
TABLE 11 KEY BUYING CRITERIA FOR VENTILATORS
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 LIST OF PATENTS IN VENTILATORS MARKET (2025)
TABLE 18 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION)
TABLE 19 EXPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)
TABLE 20 IMPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)
TABLE 21 VENTILATORS MARKET: KEY CONFERENCES AND EVENTS, 2023-2024
TABLE 22 REIMBURSEMENT SCENARIO IN VENTILATORS MARKET
TABLE 23 UNMET NEEDS IN VENTILATORS MARKET
TABLE 24 END-USER EXPECTATIONS IN VENTILATORS MARKET
TABLE 25 VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 26 INTENSIVE CARE VENTILATORS: KEY PRODUCTS
TABLE 27 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 28 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 29 INTENSIVE CARE VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
TABLE 30 HIGH-END ICU VENTILATORS: KEY PRODUCTS
TABLE 31 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 32 HIGH-END ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
TABLE 33 MID-END ICU VENTILATORS: KEY PRODUCTS
TABLE 34 MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 35 MID-END ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
TABLE 36 BASIC ICU VENTILATORS: KEY PRODUCTS
TABLE 37 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 38 BASIC ICU VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
TABLE 39 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS
TABLE 40 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021-2029 (THOUSAND UNITS)
TABLE 42 VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 43 ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS
TABLE 44 ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 45 NEONATAL/INFANT VENTILATORS: KEY PRODUCTS
TABLE 46 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 47 VENTILATION MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 48 HYBRID VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 49 NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 50 INVASIVE VENTILATION MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 51 VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 52 COMBINED-MODE VENTILATORS: KEY PRODUCTS
TABLE 53 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 54 VOLUME-MODE VENTILATORS: KEY PRODUCTS
TABLE 55 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 56 PRESSURE-MODE VENTILATORS: KEY PRODUCTS
TABLE 57 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 58 OTHER VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 59 VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 60 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 61 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 62 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 63 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 64 VENTILATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
TABLE 65 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 67 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 68 NORTH AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 69 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 70 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 71 NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 72 US: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 73 US: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 74 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 75 US: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 76 US: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 77 US: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 78 US: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 79 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
TABLE 80 CANADA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 81 CANADA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 82 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 83 CANADA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 84 CANADA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 85 CANADA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 86 CANADA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 87 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 88 EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 89 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 90 EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 91 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 92 EUROPE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 93 EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 94 GERMANY: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 95 GERMANY: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 96 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 97 GERMANY: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 98 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 99 GERMANY: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 100 GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 101 FRANCE: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 102 FRANCE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 103 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 104 FRANCE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 105 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 106 FRANCE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 107 FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 108 UK: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 109 UK: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 110 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 111 UK: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 112 UK: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 113 UK: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 114 UK: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 115 ITALY: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 116 ITALY: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 117 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 118 ITALY: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 119 ITALY: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 120 ITALY: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 121 ITALY: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 122 SPAIN: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 123 SPAIN: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 124 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 125 SPAIN: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 126 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 127 SPAIN: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 128 SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 129 NETHERLANDS: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 130 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 131 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 132 NETHERLANDS: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 133 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 134 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 135 NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 136 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 137 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 138 REST OF EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 139 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 140 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 141 REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 143 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 144 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 145 ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 146 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 147 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 148 ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 149 JAPAN: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 150 JAPAN: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 151 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 152 JAPAN: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 153 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 154 JAPAN: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 155 JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 156 CHINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 157 CHINA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 158 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 159 CHINA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 160 CHINA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 161 CHINA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION).
TABLE 162 CHINA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 163 INDIA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 164 INDIA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 165 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 166 INDIA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 167 INDIA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 168 INDIA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 169 INDIA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 170 AUSTRALIA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 171 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 172 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 173 AUSTRALIA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 174 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 175 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 176 AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 178 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 179 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 180 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 181 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 182 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 183 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
TABLE 184 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 185 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 186 LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 187 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 188 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 189 LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 190 BRAZIL: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 191 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 192 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 193 BRAZIL: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 194 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 195 BRAZIL: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 196 BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 197 MEXICO: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 198 MEXICO: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 199 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 200 MEXICO: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 201 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 202 MEXICO: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 203 MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 204 ARGENTINA: KEY MACROINDICATORS FOR VENTILATORS MARKET
TABLE 205 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 206 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 207 ARGENTINA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 208 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 209 ARGENTINA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 210 ARGENTINA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 215 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 216 REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 223 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 224 GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
TABLE 225 GCC COUNTRIES: VENTILATORS MARKET, BY AGE GROUP, 2021-2029 (USD MILLION)
TABLE 226 GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE, 2021-2029 (USD MILLION)
TABLE 227 GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2021-2029 (USD MILLION)
TABLE 228 GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING, 2021-2029 (USD MILLION)
TABLE 229 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VENTILATORS MARKET, 2021-2025
TABLE 230 VENTILATORS MARKET: DEGREE OF COMPETITION
TABLE 231 VENTILATORS MARKET: REGION FOOTPRINT
TABLE 232 VENTILATORS MARKET: TYPE FOOTPRINT
TABLE 233 VENTILATORS MARKET: AGE GROUP FOOTPRINT
TABLE 234 VENTILATORS MARKET: INTERFACE FOOTPRINT
TABLE 235 VENTILATORS MARKET: MODE FOOTPRINT
TABLE 236 VENTILATORS MARKET: CARE SETTING FOOTPRINT
TABLE 237 VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 238 VENTILATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 239 VENTILATORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 240 VENTILATORS MARKET: DEALS, JANUARY 2021-JANUARY 2025
TABLE 241 VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 242 RESMED: BUSINESS OVERVIEW
TABLE 243 RESMED: PRODUCTS OFFERED
TABLE 244 RESMED: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 245 GETINGE AB: BUSINESS OVERVIEW
TABLE 246 GETINGE AB: PRODUCTS OFFERED
TABLE 247 GETINGE AB: PRODUCT APPROVALS, JANUARY 2021-JANUARY 2025
TABLE 248 GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 249 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 250 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 251 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 252 DRAGERWERK AG & CO. KGAA: BUSINESS OVERVIEW
TABLE 253 DRAGERWERK AG & CO. KGAA: PRODUCTS OFFERED
TABLE 254 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 255 DRAGERWERK AG & CO. KGAA: DEALS, JANUARY 2021-JANUARY 2025
TABLE 256 DRAGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 257 ICU MEDICAL INC.: BUSINESS OVERVIEW
TABLE 258 ICU MEDICAL, INC.: PRODUCTS OFFERED
TABLE 259 ICU MEDICAL, INC.: DEALS, JANUARY 2021-JANUARY 2025
TABLE 260 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
TABLE 261 ASAHI KASEI CORPORATION: PRODUCTS OFFERED
TABLE 262 ASAHI KASEI MEDICAL: DEALS, JANUARY 2021-JANUARY 2025
TABLE 263 AIR LIQUIDE: BUSINESS OVERVIEW
TABLE 264 AIR LIQUIDE: PRODUCTS OFFERED
TABLE 265 AIR LIQUIDE: DEALS, JANUARY 2021-JANUARY 2025
TABLE 266 FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW
TABLE 267 FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED
TABLE 268 FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021-JANUARY 2025
TABLE 269 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
TABLE 270 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED
TABLE 271 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-JANUARY 2025
TABLE 272 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW
TABLE 273 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED
TABLE 274 GE HEALTHCARE: BUSINESS OVERVIEW
TABLE 275 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 276 GE HEALTHCARE: DEALS, JANUARY 2021-JANUARY 2025
TABLE 277 BAXTER: BUSINESS OVERVIEW
TABLE 278 BAXTER: PRODUCTS OFFERED
TABLE 279 BAXTER: DEALS, JANUARY 2021-JANUARY 2025
TABLE 280 VYAIRE MEDICAL, INC: BUSINESS OVERVIEW
TABLE 281 VYAIRE MEDICAL, INC: PRODUCTS OFFERED
TABLE 282 VYAIRE MEDICAL, INC: DEALS, JANUARY 2021-JANUARY 2025
TABLE 283 VYAIRE MEDICAL, INC: OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025
TABLE 284 HAMILTON MEDICAL: BUSINESS OVERVIEW
TABLE 285 HAMILTON MEDICAL: PRODUCTS OFFERED
TABLE 286 HAMILTON MEDICAL: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025

List of Figures

FIGURE 1 VENTILATORS MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. (NETHERLANDS) (2024)
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION
FIGURE 10 DEMAND-SIDE MARKET SIZE ESTIMATION
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2024-2029)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
FIGURE 14 DATA TRIANGULATION METHODOLOGY
FIGURE 15 VENTILATORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 16 VENTILATORS MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2024 VS. 2029 (USD MILLION)
FIGURE 18 VENTILATORS MARKET, BY MODE, 2024 VS. 2029 (USD MILLION)
FIGURE 19 VENTILATORS MARKET, BY CARE SETTING, 2024 VS. 2029 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF VENTILATORS MARKET
FIGURE 21 RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET
FIGURE 22 INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2024
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 24 NORTH AMERICA WILL DOMINATE THE MARKET TILL 2029
FIGURE 25 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES OVER FORECAST PERIOD
FIGURE 26 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 27 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2024
FIGURE 28 GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015-2023
FIGURE 29 ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019-NOVEMBER 2023
FIGURE 30 AVERAGE SELLING PRICE TREND FOR HIGH-END VENTILATORS, BY REGION, 2022-2024 (USD)
FIGURE 31 VENTILATORS MARKET: VALUE CHAIN ANALYSIS
FIGURE 32 VENTILATORS MARKET: ECOSYSTEM ANALYSIS
FIGURE 33 SUPPLY CHAIN ANALYSIS
FIGURE 34 VENTILATORS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS
FIGURE 36 KEY BUYING CRITERIA FOR VENTILATORS
FIGURE 37 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS), JANUARY 2015-FEBRUARY 2025
FIGURE 38 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 39 NUMBER OF DEALS AND FUNDING IN VENTILATORS MARKET, 2019-2023 (USD MILLION)
FIGURE 40 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019-2023
FIGURE 41 VALUE OF INVESTOR DEALS, BY KEY PLAYERS, 2019-2023 (USD MILLION)
FIGURE 42 RESPIRATORY DIAGNOSTICS MARKET OVERVIEW
FIGURE 43 SLEEP APNEA DEVICES MARKET OVERVIEW
FIGURE 44 AI INTEGRATION FOR VENTILATORS
FIGURE 45 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
FIGURE 46 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT
FIGURE 47 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT
FIGURE 48 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2019-2023)
FIGURE 49 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2023)
FIGURE 50 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 51 VENTILATORS MARKET: COMPANY FOOTPRINT
FIGURE 52 VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2022 VS. 2023)
FIGURE 54 EV/EBITDA OF KEY VENDORS
FIGURE 55 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 56 BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 57 RESMED: COMPANY SNAPSHOT (2023)
FIGURE 58 GETINGE AB: COMPANY SNAPSHOT (2023)
FIGURE 59 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
FIGURE 60 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)
FIGURE 61 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023)
FIGURE 62 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 63 AIR LIQUIDE: COMPANY SNAPSHOT (2023)
FIGURE 64 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 65 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2023)
FIGURE 66 GE HEALTHCARE: COMPANY SNAPSHOT (2023)
FIGURE 67 BAXTER: COMPANY SNAPSHOT (2023)

Product Code: MD 4529

The ventilators market is projected to reach USD 4.66 Billion by 2029 from USD 3.71 Billion in 2024 at a CAGR of 4.7% during the forecast period.

Scope of the Report
Years Considered for the Study	2021-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	By Type, Age group, Interface, Mode, Care Setting and Region
Regions covered	North America, Europe, APAC, Latin America, Middle East & Africa, GCC Countries

Increscent respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and ageing populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology-safety, accuracy, and patient outcomes-prompt healthcare professionals to invest in newer respiratory support equipment. In sum, the increasing burden of respiratory illnesses is driving market growth.

"The High-end ICU ventilators segment is accounted for the largest share of global ventilators market."

Premium ICU ventilators have the largest market share of the worldwide ventilators market due to the fact that they are essential in the treatment of life-threatening situations in intensive care units. Such high-end equipment has a comprehensive variety of ventilation modes, advanced monitoring systems, and improved safety features that are necessary for critical patients. With the aging worldwide population and prevalence of sophisticated respiratory diseases, healthcare facilities are aggressively investing in next-generation ICU solutions. In addition, ongoing development and strict standards imposed by regulative bodies support the use of these advanced devices, making them the go-to option in life-critical applications where the utmost patient outcomes must be achieved.

"Combined mode ventilation has the largest market share in ventilators market."

Combined mode ventilators command the highest market share in the ventilators segment due to the fact that they provide the most advantageous aspects of volume- and pressure-controlled ventilation, allowing clinicians to customize respiratory support to the individual needs of a patient. The products allow clinicians to accurately control tidal volumes while also limiting pressure so that the lungs are not injured, thereby giving a versatile solution that can work in a number of clinical circumstances. Their paired, high-tech monitoring systems and automated adjustments do not only add convenience but also improve patient results. Accordingly, combined mode ventilators are in great demand among intensive care units with critically ill patients who need dynamic and flexible modes of ventilation. In addition, unbroken technology innovation, increased spending on healthcare facilities, and increasing instances of respiratory diseases have each played a role to drive combined mode ventilators to the top of the market.

"Europe holds the second largest market share in the ventilators market."

Europe is the world's second-largest ventilator market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with high incidence of respiratory conditions and the ageing population, all ensure rising demand for invasive as well as non-invasive ventilators.

Moreover, Europe is favored with a vibrant community of top-notch producers and never-ending innovation, leading to the development of ultra-modern technologies that improve patient results. Together with forward-looking healthcare measures and all-encompassing insurance coverage, Europe is a strong market for ventilators worldwide, guaranteeing its position as the second largest market share holder.

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

By Company Type: Tier 1-25%, Tier 2-40%, and Tier 3-35%
By Designation: C-level-20%, Director Level-38%, and Others-40%
By Region: North America-37%, Europe-28%, Asia Pacific-26%, Latin America- 6%, and Middle East and Africa- 1% and GCC Countries- 2%

Prominent players in this market include ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Asahi Kasei Corporation (Japan), Air Liquide (France), Flexicare (Group) Limited (UK), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), GE Healthcare (US), Baxter (US), Vyaire Medical, Inc. (US), Hamilton Medical (Switzerland), Skanray Technologies (India), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingenieria SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany) and AgVa Healthcare (India).

Research Coverage:

The market study covers the ventilators market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, age group, interface, mode, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of Market Dynamics: Drivers (Rise in respiratory diseases

Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide, Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases) restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns) opportunities (Cost-efficiency of home care services, growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)

Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Dragerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED & REGIONS CONSIDERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY RESEARCH
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY RESEARCH
  - 2.1.2.1 Key data from primary sources
  - 2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
- 2.5.1 SCOPE-RELATED LIMITATIONS
- 2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 VENTILATORS MARKET OVERVIEW
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE AND COUNTRY (2024)
4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 VENTILATORS MARKET: REGIONAL MIX
4.5 VENTILATORS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Rise in respiratory diseases
    - 5.2.1.1.1 Increasing incidences of COPD and asthma
    - 5.2.1.1.2 High prevalence of tobacco smoking
  - 5.2.1.2 Urbanization and rising pollution levels
  - 5.2.1.3 Rising obesity due to sedentary lifestyles
  - 5.2.1.4 Growing geriatric population worldwide
  - 5.2.1.5 Increasing preference for home care settings
  - 5.2.1.6 Rising number of preterm births
  - 5.2.1.7 Outbreak of infectious respiratory diseases
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Shortage of skilled medical workers
  - 5.2.2.2 Excessive purchase of ventilators during COVID-19
  - 5.2.2.3 Reimbursement concerns
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Cost-efficiency of home care services
  - 5.2.3.2 Growth opportunities in emerging economies
- 5.2.4 CHALLENGES
  - 5.2.4.1 Low awareness and inadequate resources in emerging economies
  - 5.2.4.2 Harmful effects of respiratory devices on neonates
  - 5.2.4.3 Supply chain disruptions
  - 5.2.4.4 Global demand fluctuations
5.3 INDUSTRY TRENDS
- 5.3.1 RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS
- 5.3.2 MARKET CONSOLIDATION
- 5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS
- 5.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS
5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
  - 5.4.1.1 Sensor technologies
    - 5.4.1.1.1 Flow sensors
    - 5.4.1.1.2 Oxygen sensors
    - 5.4.1.1.3 Pressure sensors
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
  - 5.4.2.1 E-nose technology
  - 5.4.2.2 MEMS technology
  - 5.4.2.3 Electrochemical technology
  - 5.4.2.4 Paramagnetic technology
  - 5.4.2.5 Wireless gas sensor technology
- 5.4.3 ADJACENT TECHNOLOGIES
  - 5.4.3.1 High-flow nasal cannula (HFNC) devices
5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER
- 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 PORTER'S FIVE FORCES ANALYSIS
- 5.9.1 THREAT OF NEW ENTRANTS
- 5.9.2 THREAT OF SUBSTITUTES
- 5.9.3 BARGAINING POWER OF SUPPLIERS
- 5.9.4 BARGAINING POWER OF BUYERS
- 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.10.2 BUYING CRITERIA
5.11 REGULATORY ANALYSIS
- 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11.2 REGULATORY FRAMEWORK
  - 5.11.2.1 North America
    - 5.11.2.1.1 US
    - 5.11.2.1.2 Canada
  - 5.11.2.2 Europe
  - 5.11.2.3 Asia Pacific
    - 5.11.2.3.1 Japan
    - 5.11.2.3.2 China
    - 5.11.2.3.3 India
    - 5.11.2.3.4 South Korea
  - 5.11.2.4 Latin America
    - 5.11.2.4.1 Brazil
    - 5.11.2.4.2 Mexico
  - 5.11.2.5 Middle East
  - 5.11.2.6 Africa
5.12 PATENT ANALYSIS
- 5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS
5.13 TRADE ANALYSIS
- 5.13.1 EXPORT DATA FOR VENTILATORS (HS CODE 9018)
- 5.13.2 IMPORT DATA FOR VENTILATORS (HS CODE 9018)
5.14 KEY CONFERENCES AND EVENTS, 2023-2024
5.15 REIMBURSEMENT SCENARIO
5.16 UNMET NEEDS AND END-USER EXPECTATIONS
- 5.16.1 UNMET NEEDS IN VENTILATORS MARKET
- 5.16.2 END-USER EXPECTATIONS IN VENTILATORS MARKET
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.18 INVESTMENT & FUNDING SCENARIO
5.19 ADJACENT MARKET ANALYSIS
- 5.19.1 RESPIRATORY DIAGNOSTICS MARKET
- 5.19.2 SLEEP APNEA DEVICES MARKET
5.20 IMPACT OF AI/GEN AI ON VENTILATORS MARKET
- 5.20.1 INTRODUCTION
- 5.20.2 FUTURE OF HEALTHCARE-BIG DATA AND AI
- 5.20.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT

6 VENTILATORS MARKET, BY TYPE

6.1 INTRODUCTION
6.2 INTENSIVE CARE VENTILATORS
- 6.2.1 HIGH-END ICU VENTILATORS
  - 6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market
- 6.2.2 MID-END ICU VENTILATORS
  - 6.2.2.1 Higher affordability and accessibility to drive market
- 6.2.3 BASIC ICU VENTILATORS
  - 6.2.3.1 Growing use in ambulatory care centers to drive market
6.3 PORTABLE/TRANSPORTABLE VENTILATORS
- 6.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET

7 VENTILATORS MARKET, BY AGE GROUP

7.1 INTRODUCTION
7.2 ADULT & PEDIATRIC VENTILATORS
- 7.2.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET
7.3 NEONATAL/INFANT VENTILATORS
- 7.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET

8 VENTILATION MARKET, BY INTERFACE

8.1 INTRODUCTION
8.2 HYBRID VENTILATION
- 8.2.1 RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET
8.3 NON-INVASIVE VENTILATION
- 8.3.1 RELIABILITY OF MECHANICAL DESIGNS TO DRIVE MARKET
8.4 INVASIVE VENTILATION
- 8.4.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET

9 VENTILATORS MARKET, BY MODE

9.1 INTRODUCTION
9.2 COMBINED-MODE VENTILATORS
- 9.2.1 COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET
9.3 VOLUME-MODE VENTILATORS
- 9.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET
9.4 PRESSURE-MODE VENTILATORS
- 9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET
9.5 OTHER VENTILATORS

10 VENTILATORS MARKET, BY CARE SETTING

10.1 INTRODUCTION
10.2 HOSPITALS & CLINICS
- 10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET
10.3 AMBULATORY CARE CENTERS
- 10.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET
10.4 EMERGENCY MEDICAL SERVICES
- 10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET
10.5 HOME CARE SETTINGS
- 10.5.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET

11 VENTILATORS MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 High prevalence of COPD to drive the market
- 11.2.3 CANADA
  - 11.2.3.1 Increasing incidence of asthma to drive market
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 GERMANY
  - 11.3.2.1 Rising healthcare spending to increase demand for high-end ventilators
- 11.3.3 FRANCE
  - 11.3.3.1 Highly advanced healthcare system to drive adoption of ventilators in hospitals
- 11.3.4 UK
  - 11.3.4.1 Increasing healthcare expenditure to drive market growth
- 11.3.5 ITALY
  - 11.3.5.1 High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market
- 11.3.6 SPAIN
  - 11.3.6.1 High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth
- 11.3.7 NETHERLANDS
  - 11.3.7.1 Rising prevalence of respiratory diseases to drive market
- 11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 JAPAN
  - 11.4.2.1 Established healthcare system to increase adoption of respiratory care devices
- 11.4.3 CHINA
  - 11.4.3.1 High prevalence of COPD and lung cancer to propel demand
- 11.4.4 INDIA
  - 11.4.4.1 Rising focus of global players on the Indian market to drive adoption of advanced ventilators
- 11.4.5 AUSTRALIA
  - 11.4.5.1 High prevalence of chronic lung diseases to drive demand for ventilators
- 11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
  - 11.5.2.1 Healthcare infrastructure improvement to support market growth
- 11.5.3 MEXICO
  - 11.5.3.1 Rising obesity rate to increase incidence rate of respiratory diseases
- 11.5.4 ARGENTINA
  - 11.5.4.1 Incidence of severe acute respiratory infections to drive market
- 11.5.5 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
- 11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET
- 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.7 GCC COUNTRIES
- 11.7.1 HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH
- 11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 2023
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Region footprint
  - 12.5.5.3 Type footprint
  - 12.5.5.4 Age group footprint
  - 12.5.5.5 Interface footprint
  - 12.5.5.6 Mode footprint
  - 12.5.5.7 Care setting footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 12.6.5.1 Detailed list of key startups/SMEs
  - 12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 VENTILATORS MARKET: R&D EXPENDITURE
12.8 COMPANY VALUATION & FINANCIAL METRICS
- 12.8.1 FINANCIAL METRICS
- 12.8.2 COMPANY VALUATION
12.9 BRAND/PRODUCT COMPARISON
12.10 COMPETITIVE SCENARIO
- 12.10.1 PRODUCT LAUNCHES & APPROVALS
- 12.10.2 DEALS
- 12.10.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 RESMED
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product launches & approvals
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Right to win
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses and competitive threats
- 13.1.2 GETINGE AB
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Product launches & approvals
    - 13.1.2.3.2 Other developments
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Right to win
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses and competitive threats
- 13.1.3 KONINKLIJKE PHILIPS N.V.
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Other developments
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Right to win
    - 13.1.3.4.2 Strategic choices
    - 13.1.3.4.3 Weaknesses and competitive threats
- 13.1.4 DRAGERWERK AG & CO. KGAA
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Product launches & approvals
    - 13.1.4.3.2 Deals
    - 13.1.4.3.3 Other developments
- 13.1.5 ICU MEDICAL INC.
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Deals
- 13.1.6 ASAHI KASEI CORPORATION
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Deals
- 13.1.7 AIR LIQUIDE
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Deals
- 13.1.8 FLEXICARE (GROUP) LIMITED
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Deals
- 13.1.9 NIHON KOHDEN CORPORATION
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products offered
  - 13.1.9.3 Recent developments
    - 13.1.9.3.1 Product launches
- 13.1.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products offered
- 13.1.11 GE HEALTHCARE
  - 13.1.11.1 Business overview
  - 13.1.11.2 Products offered
  - 13.1.11.3 Recent developments
    - 13.1.11.3.1 Deals
- 13.1.12 BAXTER
  - 13.1.12.1 Business overview
  - 13.1.12.2 Products offered
  - 13.1.12.3 Recent developments
    - 13.1.12.3.1 Deals
- 13.1.13 VYAIRE MEDICAL, INC.
  - 13.1.13.1 Business overview
  - 13.1.13.2 Products offered
  - 13.1.13.3 Recent developments
    - 13.1.13.3.1 Deals
    - 13.1.13.3.2 Other developments
- 13.1.14 HAMILTON MEDICAL
  - 13.1.14.1 Business overview
  - 13.1.14.2 Products offered
  - 13.1.14.3 Recent developments
    - 13.1.14.3.1 Product enhancements
13.2 OTHER PLAYERS
- 13.2.1 SKANRAY TECHNOLOGIES, LTD.
- 13.2.2 AXCENT MEDICAL GMBH
- 13.2.3 METRAN CO., LTD.
- 13.2.4 MAGNAMED
- 13.2.5 LEISTUNG INGENIERIA SRL
- 13.2.6 AVASARALA TECHNOLOGIES LIMITED
- 13.2.7 AIRON CORPORATION
- 13.2.8 TRITON ELECTRONIC SYSTEMS LTD.
- 13.2.9 BIO-MED DEVICES, INC.
- 13.2.10 HEYER MEDICAL AG
- 13.2.11 AGVA HEALTHCARE
- 13.2.12 BIODESIGN INNOVATION LABS
- 13.2.13 NOCCARC ROBOTICS PVT LTD
- 13.2.14 UMBULIZER
- 13.2.15 SCHILLER HEALTHCARE INDIA PVT. LTD
- 13.2.16 AVI HEALTHCARE

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

人工呼吸器の世界市場：可動性別、タイプ別、インターフェース別、方式別、ケア環境別 - 予測（～2029年）

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029

目次

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場の概要

第6章人工呼吸器市場：タイプ別

第7章人工呼吸器市場：年齢層別

第8章換気市場：インターフェース別

第9章人工呼吸器市場：方式別

第10章人工呼吸器市場：ケア環境別

第11章人工呼吸器市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録

List of Tables

List of Figures

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

Research Coverage:

This report provides insights on:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VENTILATORS MARKET, BY TYPE

7 VENTILATORS MARKET, BY AGE GROUP

8 VENTILATION MARKET, BY INTERFACE

9 VENTILATORS MARKET, BY MODE

10 VENTILATORS MARKET, BY CARE SETTING

11 VENTILATORS MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

人工呼吸器の世界市場：可動性別、タイプ別、インターフェース別、方式別、ケア環境別 - 予測（～2029年）

Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場の概要

第6章 人工呼吸器市場：タイプ別

第7章 人工呼吸器市場：年齢層別

第8章 換気市場：インターフェース別

第9章 人工呼吸器市場：方式別

第10章 人工呼吸器市場：ケア環境別

第11章 人工呼吸器市場：地域別

第12章 競合情勢

第13章 企業プロファイル

第14章 付録

List of Tables

List of Figures

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

Research Coverage:

This report provides insights on:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 VENTILATORS MARKET, BY TYPE

7 VENTILATORS MARKET, BY AGE GROUP

8 VENTILATION MARKET, BY INTERFACE

9 VENTILATORS MARKET, BY MODE

10 VENTILATORS MARKET, BY CARE SETTING

11 VENTILATORS MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

第1章イントロダクション

第2章調査手法

第3章エグゼクティブサマリー

第4章重要考察

第5章市場の概要

第6章人工呼吸器市場：タイプ別

第7章人工呼吸器市場：年齢層別

第8章換気市場：インターフェース別

第9章人工呼吸器市場：方式別

第10章人工呼吸器市場：ケア環境別

第11章人工呼吸器市場：地域別

第12章競合情勢

第13章企業プロファイル

第14章付録